A Review on: Mucoadhesive Drug Delivery Systems

Fuente: Zenodo
Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: A. B. Udar*, Aman Prajapati, Manoj Rahinj
Format: Recurso digital
Veröffentlicht: Zenodo 2025
Schlagworte:
Online-Zugang:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1866901256382971904
author A. B. Udar*, Aman Prajapati, Manoj Rahinj
author_facet A. B. Udar*, Aman Prajapati, Manoj Rahinj
contents <p><span>Mucoadhesive drug delivery systems (MDDS) represent a novel approach to improve therapeutic effectiveness by utilizing the adhesive interaction between polymers and the mucosal surface. These systems enhance drug residence time, increase absorption, and bypass hepatic first-pass metabolism, thereby improving the bioavailability of drugs with poor oral absorption. MDDS have been developed for multiple routes, including oral, buccal, nasal, vaginal, rectal, ocular, and gastrointestinal delivery, using dosage forms such as tablets, films, gels, microspheres, nanoparticles, and sprays. The mechanism of mucoadhesion is explained through various theories electronic, adsorption, wetting, diffusion, and fracture and is influenced by polymer type, hydration, pH, and mucosal physiology. Both natural and synthetic polymers, including chitosan, Carbopol, and cellulose derivatives, are widely used to achieve desirable adhesion and controlled release. Evaluation parameters involve mechanical strength, bioadhesive force, swelling studies, in vitro dissolution, permeability, and in vivo pharmacokinetic assessments. Despite certain limitations, such as dose restrictions and mucosal variability, continuous advances in polymer science, nanotechnology, and smart delivery carriers are expanding the clinical potential of MDDS. With increasing patient compliance and several marketed formulations, mucoadhesive systems continue to be a promising and rapidly growing area in pharmaceutical research. </span></p>
format Recurso digital
id zenodo_https___doi_org_10_5281_zenodo_17552140
institution Zenodo
language
publishDate 2025
publisher Zenodo
record_format zenodo
spellingShingle A Review on: Mucoadhesive Drug Delivery Systems
A. B. Udar*, Aman Prajapati, Manoj Rahinj
Mucoadhesion, Bioadhesive polymers, Controlled drug delivery, Buccal patches, Nanocarriers, Patient compliance
<p><span>Mucoadhesive drug delivery systems (MDDS) represent a novel approach to improve therapeutic effectiveness by utilizing the adhesive interaction between polymers and the mucosal surface. These systems enhance drug residence time, increase absorption, and bypass hepatic first-pass metabolism, thereby improving the bioavailability of drugs with poor oral absorption. MDDS have been developed for multiple routes, including oral, buccal, nasal, vaginal, rectal, ocular, and gastrointestinal delivery, using dosage forms such as tablets, films, gels, microspheres, nanoparticles, and sprays. The mechanism of mucoadhesion is explained through various theories electronic, adsorption, wetting, diffusion, and fracture and is influenced by polymer type, hydration, pH, and mucosal physiology. Both natural and synthetic polymers, including chitosan, Carbopol, and cellulose derivatives, are widely used to achieve desirable adhesion and controlled release. Evaluation parameters involve mechanical strength, bioadhesive force, swelling studies, in vitro dissolution, permeability, and in vivo pharmacokinetic assessments. Despite certain limitations, such as dose restrictions and mucosal variability, continuous advances in polymer science, nanotechnology, and smart delivery carriers are expanding the clinical potential of MDDS. With increasing patient compliance and several marketed formulations, mucoadhesive systems continue to be a promising and rapidly growing area in pharmaceutical research. </span></p>
title A Review on: Mucoadhesive Drug Delivery Systems
topic Mucoadhesion, Bioadhesive polymers, Controlled drug delivery, Buccal patches, Nanocarriers, Patient compliance
url https://doi.org/10.5281/zenodo.17552140